Page 33 - Third Bancorp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) have been given an average rating of “Moderate Buy” by the seventeen brokerages that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 12 […]

CenterPoint Energy, Inc. (NYSE:CNP – Get Free Report) has been assigned an average rating of “Hold” from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and six have issued a buy recommendation on the company. […]

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 1-year target price among analysts […]

Pinnacle Financial Partners, Inc. (NASDAQ:PNFP – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among […]

Cytokinetics (NASDAQ:CYTK – Get Free Report) had its target price decreased by equities research analysts at Truist Financial from $86.00 to $70.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. Truist Financial’s price target would indicate a potential upside of 45.20% from […]